OREX (Orexigen Therapeutics, Inc) was chosen by none other than Rowan Jenkins, Chief Investor of Ivy Investment Group, 3 weeks ago.
The FDA approved its diet pill today and the shares soared over 100%. The best part is that our investors already had the stock in their portfolios.
If investors want to be with a true winner, then choose Ivy Investment Group at www.theivyinvestmentgroup.com
Ivy, Whitfield, and Associates, G.P.